Notably, one patient developed pneumococcal meningitis, and one received only two doses of rituximab because of a hypersensitivity reaction ... treated with subcutaneous EPO-α, in whom ...
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
Kennedy’s confirmation fight featured an array of outside actors, on both sides, working to channel those strong reactions into pleas to senators in hopes of swaying their votes. While outside ...
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma. The treatment combination of Calquence ...
The Philadelphia Eagles are champions again -- in dominant fashion. The Eagles defeated the Kansas City Chiefs 40-22 on Sunday night in Super Bowl LIX. It's the second Super Bowl victory in ...
These are self-administered directly into the muscle (intramuscular) or underneath the skin (subcutaneous). Depending on the medication, they are given every other day to once every 14 days.
Calquence's approval with bendamustine and Rituxan offers a new first-line treatment for MCL patients ineligible for HSCT, marking a significant therapeutic advancement. Clinical trials showed ...
That is your lot for tonight. You don't have to wait long for more FA Cup action as Doncaster entertain Crystal Palace tomorrow. Thanks for joining us and for your comments. Enjoy the rest of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback